TABLE 1.
Type | Activity | Continuous-time models | Discrete-time models | Experimental techniques |
---|---|---|---|---|
Cells | Random motility | 1) Fick’s second law, e.g. diffusion coefficient estimated from molecular weight or experimental dataa; 2) Haptokinetic process, e.g. influenced by total matrix density such that cells cannot move in absence or abundance of ECM densityb | Each agent moves in one of the empty surrounding positions chosen randomly by the algorithmi,j,m–q | Brightfield microscopy can quantify cell migration in organ-on-chip systemsr [cell velocity: distance/time] |
Chemotaxis | Receptor-ligand kinetics, e.g. maximum chemotactic response at certain growth factor concentrationc | The selection of the surrounding position during migration is not random but it is biased by the concentration of the chemotactic factori,o,q | Organ-on-chip systems facilitate the application of chemical gradientsr [diffusion of the leading edge of chemical: distance/time] | |
Haptotaxis | Haptotactic process, e.g. based on a kinetic analysis of a model mechanism for the cell-surface-receptor-extracellular-ligand binding dynamicsb | The selection of the surrounding position during migration is not random but it is biased according to the composition and fiber orientation of ECMa,f,k | Organ-on-chip systems facilitate the application of density gradientsr [binding concentration: mass/volume] | |
Differentiation | Concentration-dependent curve, e.g. Hill function regulated by the concentration of growth factorse or oxygenf up to a saturation level | The agent changes its phenotype status according to the surrounding environmental conditionsj,n,q | Analysis of cell surface markers (e.g. flow cytometry) [% of positive cells], gene expression profiles (e.g. qPCR and RNA-seq) [fold change in gene expression] and stainings (e.g. Alizarin Red for osteogenic differentiation)s [qualitative observation] | |
Polarization/activation | Concentration-dependent curve, e.g. Hill function regulated by the concentration of cytokines up to a saturation levelg | The agent changes its activation status according to the surrounding environmental conditionsi,m,o,p | Analysis of cell surface markers (e.g. flow cytometry) (% of positive cells) and gene expression profiles (e.g. qPCR and RNA-seq) (qualitative observation)t | |
Proliferation | Fisher equation and logistic growth function such that rate of cell division decreases linearly with cell density, e.g. regulated by ECM densityb or oxygen tensiond | A proliferative agent creates a copy of itself in one of the empty surrounding positions chosen randomly by the algorithmj,l–q | Proliferation assays based on DNA synthesis (e.g. EdU assay) [% of proliferating cells] or metabolic activity (e.g. MTT assay) (arbitrary units)s | |
Apoptosis | 1) Rate estimated from experimental datae; 2) Concentration-dependent curve, e.g. Hill function regulated by oxygen tension up to a saturation leveld | The apoptotic agent is removed from the modeli,j,l,m,o,p,q; nutrient-related survival conditions are applied by increasing the apoptosis ratio in undesired conditionsn | Depending on the apoptosis stage, fluorimetric assays detecting mito-chondrial degradation, caspase activation or DNA fragmentation [% of viable cells] | |
Senescence | Cell differentiation as evolutionary process, e.g. cells gain properties of another cell type gradually over timeg | The senescent agent gradually reduces its cellular activity to zero (not performing actions, but not removed from the model) | Staining of SA-β-gal [qualitative observation] | |
Chemical agents (cytokines, growth factors, hormones, etc.) | Diffusion | Fick’s second law, e.g. diffusion coefficient estimated from molecular weight or experimental dataa | Discretized Fick’s first law: the amount of substance exchanged between two adjacent patches is proportional to concentration difference, diffusing from patch of higher concentration to patch of lower onei,p,q | The biomolecule distribution across an hydrogel can be quantified with immunoassays (e.g ELISA) [biomolecule concentration: mass/volume]r |
Production | 1) Rate estimated from experimental dataa; 2) Concentration-dependent curve, e.g. Hill function to model a threshold-like behaviore | Substance concentration increases in function of the number of agents present in the patch according to a defined production ratioi,n,p,q | Immunoassays to quantify protein synthesis (e.g. ELISA)u [biomolecule concentration: mass/volume] | |
Consumption | Michaelis-Menten kinetic law, e.g. oxygen consumption by cellsh | Substance concentration decreases in function of the number of agents present in the patch according to a defined consumption ratioq | Metabolites labeled with stable isotope tracers (e.g glucose consumption or fatty acid uptake) [normalized metabolite consumption: molarity/(time ⋅ mass)]t | |
Denaturation | Rate estimated from experimental dataa | Substance decay within patch decreases by following a time-dependent exponential functioni,o,p,q | Biomolecule half-life estimation (e.g. pulse-chase analysis for cellular proteins) [time] | |
Extracellular matrix | Synthesis | Rate estimated from experimental datab | Matrix percentage increases within the patch where the cell is localized according to a synthesis ratioj,q | Cells/ECM growth can be evaluated with a Live-Dead viability/cytotoxicity staining [volume fraction: %]v |
Degradation | Rate estimated from experimental datab | Matrix percentage decreases within the patch where the cell is localized according to degradation ratioq | Level of biomolecules associated to degradation (e.g. hydroxyproline for collagen matrix) [biomolecule concentration: mass/volume] | |
Debris | Phagocytosis | Concentration-dependent curve, e.g. Hill function to model engulfing rateg | Phagocytic agent reduces the debris concentration within a defined radius of actionl,o | Phagocytes culture (e.g. macrophages) with cellular debris or pathogens [cytokine concentration: mass/volume]w |
Angiogenesis | Vessel formation | Migration (random and directed)a and proliferationc of endothelial cells, finally producing vascular matrix | Development of vasculature according to tip endothelial cell movementa,f,k,n | Microscopy imaging, brightfieldx or confocaly, of an endothelial cell monolayer during sprouting [sprout displacement: length |
References: a Anderson and Chaplain (1998), b Olsen et al. (1997), c Geris et al. (2008), d Carlier et al. (2015), e Bailón-Plaza and Van Der Meulen (2001), f Carlier et al. (2012), g Trejo et al. (2019), h Prokharau et al. (2012), i Mi et al. (2007), j Checa et al. (2011), k Peiffer et al. (2011), l Martínez et al. (2012), m Pennisi et al. (2013), n OReilly et al. (2016), o Shi et al. (2016), p Gong et al. (2017), q Borgiani et al. (2021), r Moreno-Arotzena et al. (2014), s Groeneveldt et al. (2020), t Vats et al. (2006), u Zhang et al. (2017), v Guyot et al. (2014), w Fraser et al. (2009), x Del Amo et al. (2016), y Vaeyens et al. (2020), Abbreviations: SA-β-gal, senescence-associated β-galactosidase; ELISA, enzyme-linked immunosorbent assay; qPCR, quantitative polymerase chain reaction; ECM, extracellular matrix; RNA-seq, RNA-sequencing.